Thanks, XXXX QX Envista's John call. and welcome everyone to earnings
quarter margin and transformative earnings, Our cash team year strong flows, a Envista. for delivered another concluding operating of
able our scanning. company, over Now that we the of been last are portfolio fully add through our acquisition to a several independent have partnerships Matricel, strategic as well to intraoral in weeks we first a as
continue business, I I want take of Before Coronavirus including events the China, outbreak. update our to moment a in to the address the
employees and well-being our most is important The of health our priority.
team impact. Chinese our in We experienced employee our are team shipment products virus. spread the minimal of organization New to health today, preventions, reduce to holiday was Year before has the the deliver leadership based help in China. our a of And constant infection base local with direct contact The to China quick
our to We to to will help contribute look continue health community. opportunities the employees and for of the
our of efficiently marked Moving XXXX handled to a The work tremendous undertaking. great of major Danaher a was a year accomplishment. milestone us. results, was marked in QX separation The and back for from Corporation organization finalization
more the proud added of to in employees part build organization have this than I'm of they XX and the ground success make we our Over months, and a hit our as have put Envista employees the the to past several that work grateful I'm them each to hard running. corporate to team.
execute us while into provide our environment dynamic need we to this instilling flexibility System, independent with in Being and company the EBS, Business Envista market fully culture. autonomy the
and competitive have to and our that the and value. with build to our mind. for humility our open-mindedness means advantage. improvement the continue foundation employees mindset the growth employees' development culture and business better. The Continuous in core a stems change from Envista We our is adaptability, This
to the create is of most and us facilitates a in routes Envista our EBS efficient to journey, sustainable unique Creating begin winning that visibility enables culture As me we a biggest are and XXXX. for performance. solutions. our culture creation opportunities our strong EBS priority and we gives upon a building challenges
our more several than from XXXX annual In initiatives. held employees CEO This Kaizen our November, locations. focused with first global accelerating we participation at on event XXX
offering In before. our leadership QX, than our larger we leaders also orientation began to ever a EBS set of
accountability teams. learned they to also are immerse and EBS and During to when delivering both is vital have growth, in this return our commitments what focus learned, it transform on margins to how tools Part a on orientation, our and influx EBS when inorganically. of we strengthen portfolio expand find organically considerable our accelerate of and to the new utilize their leaders apply them With required our such EBS. they and fundamentals employees, of to and
XXXX, In several around progress in initiatives growth made areas. we our key
market. capacity expansion product in Specifically, aligner a our now clear and for we the have Spark, built U.S. broader rollout for further of positioned the are
in recently and and shipped first Spark received December. also in approval China case to sell regulatory manufacture We commercial our
We invest capabilities, up in and we more Envista XXXX. the and will basis Spark demand year growth throughout will than ramp as for continue add XX to expand anticipate points of
orthodontics of and services businesses clinical market. and encouraged fastest-growing helping broader are procedures established specialty expand a a to customer dedicated with Two capture solely the of to years dental service their of and one progress these by provide organizations DSOs, implants the spending. larger customer segments our professionals and the U.S. team ago, in practices We grow or dental in their we share
over increase years. more to was DSOs collectively their top will growth XX% XX volume the in at believe, we several sales Envista's next and look XXXX, customers the than significantly DSO
digits noteworthy. XXXX markets. performance the these sales regions with in been they finished year from mid-single market XX% of also our has grew and These emerging Our
another We are with particularly pleased growth. which double-digit had performance, China's year of
and XXXX deliver the China for confident our we growth More segment With technologies core in importantly, XXXX. products low within are over Envista sales specialty grew year. our progress, XX% will single-digit
productivity the with pleased our margin. operating that initiatives. from made traction We're we have to Turning
million expenses our our on $XX of savings than improvement reduced In moderating across combination productivity the priorities. a initiatives We remain while our committed through more spending. business by we reinvesting the strategic also in discretionary initiatives executing a to and operating fourth growth quarter, have
further opportunities move our margin have forward. to as We accelerate we
to better Finally, company our we as a the cash standalone portfolio going the position to have that position flow now agility and leverage we started forward.
this biomaterials time. Last catalyst to closed will oral a used biomaterial Matricel week, category we the enable the acquisition and Matricel, procedures. implants will our growth of manufacturer membranes implant other producing The over increase exposure to and a acquisition dental be in our in businesses fast-growing for surgery
performance core impacted growth to to million, decreased demand implant fourth X.X% turn let's and the to Revenue primarily in products due in from X.X%, X% Now with our Sales X% equipment discontinued rationalization from growth lower business currency. adversely by and quarter. value our foreign was business. our declined $XXX product
weaker and Geographically, double-digit led due growth consumables business. implant in in quarter China, developed growth. markets by was equipment rate mid-single-digit our Emerging which decreased to demand primarily of at a market another experienced
due declined and mix Gross a new margin XX% and revenue in points continued basis favorable decrease to XXX to in product investment capacity.
savings moderated. company of our excluding margin million Adjusted XX impact $X decreased operating XX margin, the operating Adjusted and points points, to spending of increased initiatives expense approximately as public basis basis incremental XX.X%. traction gained profit
cash invest adjusted full flow strong to flow ratio investments. conversion organically for XXXX was our free gives earnings EPS was expectations. free us million the $XXX Our which net free and our XXX%. $X.XX, Fourth and expansion the capacity through was cash This and to opportunity quarter through year productivity cash M&A exceeded flow diluted
our now segments. business two to Turning
basis were points segment, due down operating technologies Our specialty initiatives. declined X.X%, sales cost XX.X%, and to products largely Adjusted X.X%. core improved revenue margin to XX reduction while profit
Ormco The one launched several introducing QX, demand Ormco launches revenue these was excellent our the year, of product fully which driven execution team XXXX finished products. in million. system the in now commercially brackets. core successful recent growth revenue XXXX full $XX has Damon and with achieved done mid-single-digit commercially by Damon job of in XXXX excess primarily strong while for been for an most new of has has
shipping first several Spark in During the with aligner, our case China. including our milestones we quarter, clear passed
over also launched approver additional workflows Spark greater new provide We to movements. doctor with tooth features streamline control software and
more As the doctors case with is scan in Spark access integrated the to part directly now scanner, intraoral three-shape trio of this giving portal. upgrade, seamlessly a Spark
We scanner also with in the similar workflow seamless near the clear a offering for be iXXX use Medit integration we'll qualified Spark future. aligners the and
excited the and We are Spark through on very through about XXXX. progress have acceleration the we made for track are
a of consolidating Our as result double-digit brands. decline the in the quarter, implant a we process business, value of are in our where implant decreased core revenue during primarily
strategic experienced of We organizational decline also result a developed anticipated. disruptive changes, market, as than in a which were more a
and better the our quarter experienced success fourth While commercial to appointed for leaders address challenges we results, future. this have these our in business impacted position
introductions, catalysts organizational our In changes, will customer performance forward, that help new several addition improve to product acquisitions going strategic key partnerships. our and have we including
We will accelerate DSOs NX the agreements our we intend the U.S., to securing system, European good new rolled in in contribute to subsequently anticipate to supply implants the DSO implant XXXX. our regions. of will In specialty to later to begin their segment, out made who business other three largest NX, be to progress multi-year procedures.
look volume these and increase their the years. to believe significantly next implant customers capabilities several We will over placement
success customers. important and driver been programs these training education an and support service portfolio, broad and Our team our have of with
to offerings sell Biocare strengthened scanning also with We recent intraoral Ormco products systems XShape through sales agreement and Nobel with equipment our force. our the
addition product business's We execution. to a and the better optimistic force to treatment service allows European us while performance image dentistry will about our The offer from of acquisition sales customers XXXX. solution our directly. improve offering to scanner We complete remain in digital through this XShape ability planning, treatment
in difficult we demand America, mid-single in core and wherein revenue comparison QX Western weaker part grew Europe digits. equipment business year-over-year X.X% and XXXX consumables declined equipment our a In due to in in our segment, North
portfolio category, where industry's largest worldwide. installed more have we Our an units the of base XXX,XXX imaging of one than is important
than XD OP making in has from four to XXXX. flexible shipments seconds of practitioners and features of offer XD in all as orthodontists, it a Our in times success users been with to maxillofacial market scan recent for the of surgeons. more a variety doubling view, general little way and nine perfect OP product ranging driver fields this solution as a
KaVo directly Greater Kerr with the segment at a enabling efficiency Spark DTX of intraoral soon also the integrate In the strong York greater and XXXX is to scanner imaging quarter, KaVo a workforce in The the will XXXX announced our their doctors with dental our point New drive entry we integration with practice. show. fastest-growing release into solution of software
further on continue XXX improved cost-reduction are basis operating margin our as to points position forward. and margin Equipment we The as in forward. we profit XX.X%, optimistic team business remains We initiatives. look innovate focused due expansion stabilizes adjusted look to move the further for Overall, to this in improving to we area ways will largely cost drive to consumables XXXX. as
is drive The to alive in system and productivity, guide accelerate Envista well continue new margin and helping organization, will us product our transformation. portfolio initiatives our business
and strength diluted our $X.XX be between driven acceleration rationalization initiating in contemplates the of of EPS and EPS core lower are between We incremental by value new full-year growth digits. adjusted We and diluted our of sales guidance core markets. impact from anticipate will net This $X.XX XXXX emerging GAAP from $X.XX. continued guidance and low-single products, implant introduction $X.XX growth
approximately results, is our interest or share of at high-single $X.XX incremental for two of incremental million these $X.XX growth high-end items, earnings digits our public approximately our range. includes Normalizing company per with our guidance or guidance the XXXX expense. $XX share per costs $XX comparison and In million earnings
future half As second from stronger not contribution any this We in a be typical in of M&A. does our line reminder, will with the earnings the anticipate seasonality. year include
and Additionally, up move year. cost new the we will as product expect growth through savings we ramp
ability and our closing, we're and deliver in performance business XXXX improved to opportunities beyond. about ahead energized In the confident in
